Total (N) | SUR + TKI (N) | RT + TKI (N) | RT + CHE (N) | p | |
---|---|---|---|---|---|
Male/female | 12/24 | 6/10 | 4/10 | 2/4 | 0.884 |
Age | |||||
Median (range) | 58 (39–72) | 56.5 (39–68) | 57.5 (45–72) | 59 (46–63) | 0.767 |
ECOG PS | |||||
0/1/2/3/4 | 20/12/4/0 | 12/4/0/0 | 6/5/3/0 | 2/3/1/0 | 0.057 |
RPA | |||||
I/II/III | 27/5 | 14/2/0 | 8/3/3 | 5/0/1 | 0.114 |
GPA | |||||
1–2/2.5–3/3.5–4 | 2/20/14 | 0/7/9 | 2/8/4 | 0/5/1 | 0.264 |
EGFR m + type | 6/10/0 (lung) | ||||
21/19/others | 15/20/1 | 6/9/0 (brain) | 7/6/1 | 2/4/0 | 0.934 |
EGFR-TKI | |||||
Gefitinib/erlotinib | 21/19 | 12/4 | 9/5 | – | 0.539 |
RT | |||||
SRS/WBRT | 16/4 | – | 12/2 | 4/2 | 0.355 |